SCHEMBL5371887

SCHEMBL5371887

Nc1ccc(-c2nc3cc(-c4ccccc4)ccc3o2)cc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 15/20 0.73
RAB9A P51151 15/20 0.73
GFER P55789 2/20 0.73
RXFP1 Q9HBX9 2/20 0.73
MEN1 O00255 7/20 0.69
KMT2A Q03164 7/20 0.69
ATM Q13315 2/20 0.69
KDM4E B2RXH2 8/20 0.62
MAPT P10636 8/20 0.62
ALDH1A1 P00352 6/20 0.62
HSD17B10 Q99714 5/20 0.62
TP53 P04637 4/20 0.62
SMN1; SMN2 Q16637 8/20 0.61
NFKB1 P19838 3/20 0.61
NFKB2 Q00653 3/20 0.61
RELA Q04206 3/20 0.61
L3MBTL1 Q9Y468 2/20 0.61
HPGD P15428 4/20 0.61
CASP3 P42574 3/20 0.60
SENP7 Q9BQF6 2/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2242224 0.92 RAB9A (0.81) NPC1RAB9AGFERRXFP1MEN1
SCHEMBL7905531 0.92 SMN1; SMN2 (0.70) NPC1RAB9AGFERRXFP1MEN1
SCHEMBL5654856 0.92 RAB9A (0.86) NPC1RAB9AGFERRXFP1MEN1
SCHEMBL29603993 0.92 RAB9A (0.86) NPC1RAB9AGFERRXFP1MEN1
SCHEMBL2244575 0.92 SMN1; SMN2 (0.70) NPC1RAB9AGFERRXFP1MEN1
SCHEMBL13528498 0.90 NPC1 (0.72) NPC1RAB9AGFERRXFP1MEN1
SCHEMBL13067483 0.89 NPC1 (0.62) NPC1RAB9AGFERRXFP1MEN1
SCHEMBL19846132 0.89 SMN1; SMN2 (0.66) NPC1RAB9AGFERRXFP1MEN1
SCHEMBL2244861 0.89 NPC1 (0.81) NPC1RAB9AGFERRXFP1MEN1
SCHEMBL19846131 0.89 SMN1; SMN2 (0.66) NPC1RAB9AGFERRXFP1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
CN-1930121-A Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER PROD INC (US) 2007-03-14 CN disclosed
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PFIZER INC 2006-11-16 US disclosed
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD NPC1 59/4885RAB9A 2271/4885GFER 3619/4885
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARG, PPARA, PPARD NPC1 74/4885RAB9A 2063/4885GFER 2976/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.